Cargando…

SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain

Detalles Bibliográficos
Autores principales:	Lens, Sabela, Miquel, Mireia, Mateos-Muñoz, Beatriz, García-Samaniego, Javier, Forns, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357504/ https://www.ncbi.nlm.nih.gov/pubmed/32673740 http://dx.doi.org/10.1016/j.jhep.2020.07.007

Ejemplares similares

Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review
por: Picchio, Camila A., et al.
Publicado: (2021)

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates
por: Lens, Sabela, et al.
Publicado: (2022)

Let’s leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world
por: Crespo, Javier, et al.
Publicado: (2021)

Incidence of depression in patients with hepatitis C treated with direct-acting antivirals
por: Egmond, Elfi, et al.
Publicado: (2019)

Early changes in brain structure, functional connectivity and neuropsychiatric symptoms after HCV infection cure with direct-acting antivirals
por: Cavero, M., et al.
Publicado: (2021)

A novel model of care for simplified testing of HBV in African communities during the COVID-19 pandemic in Spain
por: Picchio, Camila A., et al.
Publicado: (2021)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

HBV and HCV Therapy
por: Lampertico, Pietro, et al.
Publicado: (2009)

Are HIV, HBV and HCV Voluntary Counseling and Testing Programs Needed in Balkans?
por: Sultana, Camelia, et al.
Publicado: (2018)

Chronic conditions and multimorbidity among West African migrants in greater Barcelona, Spain
por: MacKinnon, Marina J., et al.
Publicado: (2023)

Resolved HBV behavior during the treatment of chronic HCV infection with direct-acting antivirals
por: Mohamed, Salem Y., et al.
Publicado: (2019)

Impact of the COVID-19 pandemic on HCV elimination in Spain
por: Buti, Maria, et al.
Publicado: (2021)

Interferon: A Sharp Sword to Overcome HCV or HBV-Related Liver Diseases?
por: Jia, Wei-Dong, et al.
Publicado: (2010)

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Cardiac Toxicity Associated with HCV Direct Antiviral Agents
por: Ucciferri, Claudio, et al.
Publicado: (2018)

HCV detection is possible during SARS CoV-2 testing; and throughout COVID-19 vaccination?
por: Crespo, Javier, et al.
Publicado: (2021)

HBV and HCV Coinfection Associated with Warm-Type Autoimmune Hemolytic Anemia: A Case Report
por: Zhang, Quan-le, et al.
Publicado: (2014)

Prevalence of HBV, HCV and HIV in Inpatients of a Mental Health Hospital in Turkey, 2011–2013
por: KARABULUT, Nuran
Publicado: (2015)

HBV and HCV Infection in Children and Adolescents
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2023)

SARS-CoV-2 massive testing: A window of opportunity to catch up with HCV elimination
por: Crespo, Javier, et al.
Publicado: (2021)

Inflammation and kidney involvement in human viral diseases caused by SARS-CoV-2, HIV, HCV and HBV
por: da Mata, Gustavo Ferreira, et al.
Publicado: (2021)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free Therapy
por: Perpiñán, Elena, et al.
Publicado: (2020)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals (†)
por: Molina-Carrión, Silvia, et al.
Publicado: (2020)

Point‐of‐care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination
por: Forns, Xavier, et al.
Publicado: (2021)

Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon
por: Gambato, Martina, et al.
Publicado: (2016)

Aminoglycosides and their potential as SARS-CoV-2 antivirals
por: Cimolai, Nevio
Publicado: (2021)

Sars-Cov-2 and risk of antiviral drug resistance
por: Vitiello, Antonio
Publicado: (2021)

Correction: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon
por: Gambato, Martina, et al.
Publicado: (2017)

HBV and HCV genotypes distribution on the territory of Belarus
por: Gasich, EL, et al.
Publicado: (2012)

Editorial: Recent Advances in HBV and HCV Immunology
por: Dustin, Lynn B., et al.
Publicado: (2015)

Therapeutic vaccines in HBV: lessons from HCV
por: Barnes, Eleanor
Publicado: (2015)

SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity
por: Anft, Moritz, et al.
Publicado: (2023)

Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum (1)H-NMR Spectroscopy
por: Embade, Nieves, et al.
Publicado: (2016)

Direct-acting Antivirals Induce Lymphoproliferative Disease Response in HCV-infected Patients: A Prospective Case Series
por: Hosry, Jeff, et al.
Publicado: (2017)

Perinatal HCV Transmission Rate in HIV/HCV Coinfected women with access to ART in Madrid, Spain
por: Domínguez-Rodríguez, Sara, et al.
Publicado: (2020)

HBV/HCV dual infection impacts viral load, antibody response, and cytokine expression differently from HBV or HCV single infection
por: Chen, Fei, et al.
Publicado: (2016)

In Vitro Antiviral Activity of some Novel Isatin Derivatives against HCV and SARS-CoV Viruses
por: Selvam, P., et al.
Publicado: (2008)

Heme and HO-1 Inhibition of HCV, HBV, and HIV
por: Schmidt, Warren N., et al.
Publicado: (2012)

Prevalence of HBV and HCV among blood donors in Kosovo
por: Fejza, Hajrullah, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_7qjn7clcev96m5th74lfbd6leb